Vice President, Head of Business Development, Transactions

Provide enterprise-level transaction leadership across a diverse portfolio of business development opportunities, partnering closely with R\u0026D, Commercial, Finance, Legal, and Search \u0026 Evaluation to assess external innovation and drive disciplined, value-creating deal decisions. Set and lead transaction strategy, including development of business cases, valuation frameworks, and deal structures, and oversee cross-functional due diligence and negotiations to successfully execute strategic transactions. Serve as a primary advisor to executive leadership and governance bodies, delivering clear, data-driven recommendations on external opportunities, including valuation, risk assessment, deal rationale, and key deal terms. Lead, mentor, and coach BD Transaction team members in deal execution and negotiations, providing guidance on complex issues, bridging gaps between parties, and ensuring alignment between business intent and contractual outcomes. Act as a thought partner to the SVP and BD Leadership Team in shaping overall BD strategy, portfolio priorities, and long-term external growth initiatives aligned with enterprise objectives. Represent Alnylam externally at the executive level, building and maintaining strong relationships with potential partners, advisors, and industry stakeholders, and articulating Alnylam\u0027s strategic vision and partnering approach. Build and sustain a high-performing BD organization, fostering a culture of excellence, accountability, collaboration, and innovation while developing next-generation BD leaders. MBA, JD, or other advanced business degree required; scientific background or strong aptitude to rapidly understand complex science and emerging technologies strongly preferred. 15+ years of progressive business development experience in the biotechnology and/or pharmaceutical industry, with significant leadership responsibility and a strong record of originating, leading, and closing multiple complex, high-value transactions. Detailed deal sheet required. Deep expertise in drug development processes and a comprehensive understanding of industry dynamics, including market trends, regulatory considerations, and the macro deal-making environment. Demonstrated ability to integrate scientific, clinical, and commercial insights into robust financial and strategic analyses, including valuations, P\u0026Ls, risk assessments, and investment structures. Exceptional negotiation skills with extensive experience shaping and reviewing term sheets and contracts to ensure alignment with strategic and commercial objectives. Proven ability to synthesize complex information, frame strategic trade-offs, and influence decision-making at the executive level. Outstanding communication and presentation skills, with the ability to clearly and persuasively engage senior internal leaders, governance bodies, and external partners. Highly collaborative, adaptable, and effective in a fast-paced, evolving environment with competing priorities. Strong people leadership and executive presence, with a track record of building, developing, and inspiring high-performing teams.